I-Mab (IMAB)
NASDAQ: IMAB
· Real-Time Price · USD
2.50
-0.08 (-3.10%)
At close: Jun 13, 2025, 3:59 PM
2.49
-0.40%
After-hours: Jun 13, 2025, 04:04 PM EDT
I-Mab Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Licensing and Collaboration Revenue | 16.81M | -249.66M | 40.12M |
| Licensing and Collaboration Revenue Growth | -106.73% | -722.37% | n/a |
| Supply Of Investigational Products Revenue | 10.83M | 28.1M | 47.91M |
| Supply Of Investigational Products Revenue Growth | -61.46% | -41.35% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.34M | 7.94M | 11.87M | 51.67M | 104.01M | 104.01M | 122.5M | 122.5M | 211.65M | 211.65M | 196.23M | 196.23M | 224.22M | 224.22M | 221.25M | 221.25M | 91.63M | 139.39M | 85.69M | 85.69M | 71.82M | 8.15M | 287.29M | 287.29M | 25.48M | 22.23M | 9.34M | 9.34M |
| Selling, General, and Administrative Revenue Growth | -7.51% | -33.14% | -77.03% | -50.32% | 0.00% | -15.09% | 0.00% | -42.12% | 0.00% | +7.86% | 0.00% | -12.48% | 0.00% | +1.34% | 0.00% | +141.45% | -34.26% | +62.67% | 0.00% | +19.31% | +781.46% | -97.16% | 0.00% | +1027.56% | +14.64% | +137.87% | 0.00% | n/a |
| Research and Development Revenue | 6.03M | 4.47M | 22.8M | 38.95M | 182.1M | 182.1M | 223.22M | 223.22M | 226.14M | 226.14M | 226.31M | 226.31M | 309.98M | 309.98M | 296.5M | 296.5M | 286.23M | 256.17M | 221.15M | 221.15M | 262.04M | 313.29M | 132.54M | 132.54M | 111.45M | 111.88M | 101.35M | 101.35M |
| Research and Development Revenue Growth | +34.75% | -80.37% | -41.47% | -78.61% | 0.00% | -18.42% | 0.00% | -1.29% | 0.00% | -0.07% | 0.00% | -26.99% | 0.00% | +4.55% | 0.00% | +3.59% | +11.73% | +15.84% | 0.00% | -15.61% | -16.36% | +136.37% | 0.00% | +18.92% | -0.38% | +10.39% | 0.00% | n/a |